Characterization of the Biological Activities of Human Luteinizing Hormone and Chorionic Gonadotropin by a Förster Resonance Energy Transfer-Based Biosensor Assay

Analytical Letters

Volumn 48, Issue 17, 2015, Pages 2799-2809

  Mazina, Olga ^a,b   Luik, Tanel ^a   Kopanchuk, Sergei ^a,b   Salumets, Andres ^b   Rinken, Ago ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b Competence Center on Health Technologies ^*  (Estonia)

Author keywords

Cyclic adenosine monophosphate biosensor; F rster resonance energy transfer; G protein coupled receptor; Human chorionic gonadotropin; Luteinizing hormone

Indexed keywords

EID: 84940556538     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032719.2015.1052140     Document Type: Article

References (22)

1. A.T.Bender,, and J.A.Beavo. 2006. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacological Reviews 58(3): 488–520. doi:10.1124/pr.58.3.5
2. S.A.Butler,, J.Luttoo, M.O.T.Freire, T.K.Abban, P.T.A.Borrelli, and R.K.Iles. 2013. Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: Hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment. Reproductive Sciences 20(9): 1038–45. doi:10.1177/1933719112472739
3. L.Casarini,, M.Lispi, S.Longobardi, F.Milosa, A.La Marca, D.Tagliasacchi, E.Pignatti, and M.Simoni. 2012. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS ONE 7(10): e46682. doi:10.1371/journal.pone.0046682
4. J.Choi,, and J.Smitz. 2014a. Luteinizing hormone and human chorionic gonadotropin: Distinguishing unique physiologic roles. Gynecological Endocrinology 30(3): 174–81. doi:10.3109/09513590.2013.859670
5. J.Choi,, and J.Smitz. 2014b. Luteinizing hormone and human chorionic gonadotropin: Origins of difference. Molecular and Cellular Endocrinology 383(1–2): 203–13. doi:10.1016/j.mce.2013.12.009
6. L.A.Cole,, S.A.Khanlian, J.M.Sutton, S.Davies, and N.D.Stephens. 2003. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clinical Biochemistry 36(8): 647–55. doi:10.1016/s0009-9120(03)00108-5
7. S.J.Hill,, C.Williams, and L.T.May. 2010. Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies. British Journal of Pharmacology 161(6): 1266–75. doi:10.1111/j.1476-5381.2010.00779.x
8. ICH Expert Working Group. Validation of analytical procedures: text and methodology Q2(R1). Proceedings of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, April 25–27, 2005
9. R.K.Iles,, P.J.Delves, and S.A.Butler. 2010. Does hCG or hCGβ play a role in cancer cell biology? Molecular and Cellular Endocrinology 329(1–2): 62–70. doi:10.1016/j.mce.2010.07.014
10. J.B.Klarenbeek,, J.Goedhart, M.A.Hink, T.W.Gadella, and K.Jalink. 2011. A mTurquoise-based cAMP sensor for both FLIM and ratiometric read-out has improved dynamic range. PLoS ONE 6(4): e19170. doi:10.1371/journal.pone.0019170
11. P.O.Kohler,, and W.E.Bridson. 1971. Isolation of hormone-producing clonal lines of human choriocarcinoma. The Journal of Clinical Endocrinology & Metabolism 32(5):683–87. doi:10.1210/jcem-32-5-683
12. O.Mazina,, A.Allikalt, A.Heinloo, R.Reinart-Okugbeni, S.Kopanchuk, and A.Rinken. 2015. cAMP assay for GPCR ligand characterization: Application of BacMam expression system. Methods in Molecular Biology 1272: 65–77. doi:10.1007/978-1-4939-2336-6_5
13. O.Mazina,, R.Reinart-Okugbeni, S.Kopanchuk, and A.Rinken. 2012. BacMam system for FRET-based cAMP sensor expression in studies of melanocortin MC1 receptor activation. Journal of Biomolecular Screening 17(8): 1096–101. doi:10.1177/1087057112449862
14. T.Müller,, J.Gromoll, and M.Simoni. 2003. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. The Journal of Clinical Endocrinology & Metabolism 88(5): 2242–49. doi:10.1210/jc.2002-021946
15. Y.Nishi,, T.Yanase, Y.-M.Mu, K.Oba, I.Ichino, M.Saito, M.Nomura, et al. 2001. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142(1): 437–45. doi:10.1210/en.142.1.437
16. C.Nordstedt,, and B.B.Fredholm. 1990. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Analytical Biochemistry 189(2): 231–34. doi:10.1016/0003-2697(90)90113-n
17. J.F.O’Connor,, N.Ellish, T.Kakuma, J.Schlatterer, and G.Kovalevskaya. 1998. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenatal Diagnosis 18(12): 1232–40. doi:10.1002/(SICI)1097-0223(199812)18:12<1232::AID-PD439>3.0.CO;2-Z
18. S.Ramu,, B.Acacio, M.Adamowicz, S.Parrett, and R.S.Jeyendran. 2011. Human chorionic gonadotropin from day 2 spent embryo culture media and its relationship to embryo development. Fertility and Sterility 96(3): 615–17. doi:10.1016/j.fertnstert.2011.06.035
19. U.H.Stenman,, and H.Alfthan. 2013. Determination of human chorionic gonadotropin. Best. Pract. Res. Clin. Endocrinol. Metab 27(6): 783–93.
20. A.Vonk,, R.Reinart, and A.Rinken. 2008. Modulation of adenylyl cyclase activity in rat striatal homogenate by dopaminergic receptors. Journal of Pharmacological Sciences 108(1): 63–70. doi:10.1254/jphs.08019fp
21. C.Xiao-Yan,, L.Jie, J.Dang, L.Tao, L.Xin-Ru, and Z.Guang-Lun. 2013. A highly sensitive electrochemiluminescence immunoassay for detecting human embryonic human chorionic gonadotropin in spent embryo culture media during IVF-ET cycle. Journal of Assisted Reproduction and Genetics 30(3): 377–82. doi:10.1007/s10815-012-9923-7
22. H.Zhang,, M.Vollmer, M.De Geyter, Y.Litzistorf, A.Ladewig, M.Durrenberger, R.Guggenheim, P.Miny, W.Holzgreve, and C.De Geyter. 2000. Characterization of an immortalized human granulosa cell line (COV434). Molecular Human Reproduction 6(2): 146–53. doi:10.1093/molehr/6.2.146